Please Note:
This profile was automatically generated using 4 references found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 4 references found on the Internet. This information has not been verified. Learn more...
Employment History
View...Web References
-
1. Chemical & Engineering News: Employment Outlook- Focus on Analytical Chemistry Careers
pubs.acs.org/cen/employment/85 - [Cached]Published on: 11/6/2006 Last Visited: 2/14/2007
"Within this already limited pool of talent, chemists with an analytical focus are even more difficult to come by," says Steven Bertram, Amgen's executive director of human resources.
...
That said, Amgen expects to hire fewer analytical chemists in 2007 than in other years, Bertram says.
...
According to Bertram, Amgen's ideal analytical chemistry candidate is someone with a B.S. or M.S. degree and two to six years of pharmaceutical industry experience in the areas of small-molecule separation, purification, and identification and/or characterization in support of early-to-late-phase small-molecule drug development. The demand for analytical chemists experienced with these new technologies will definitely grow as new instrumentation, technologies, and methodologies are developed to optimize and streamline the early drug development processes, he says.
"Furthermore," Bertram adds, "as our small-molecule pipeline expands and more and more molecules move from early discovery to early process development and on from there, we will undoubtedly need to bring in additional talent with the appropriate analytical chemistry experience." -
2. Chemical & Engineering News: Employment Outlook - Drug Discovery And Development
pubs.acs.org/cen/employment/84 - [Cached]Published on: 11/7/2005 Last Visited: 1/9/2007
According to Steve Bertram, director of human resources for Amgen's research division, R&D there focuses on serious illness. Rather than limiting itself to only one type of therapeutic agent, such as small or large molecules, it develops agents that best fit the target. After testing a potential drug for efficacy in lab animals and healthy human volunteers, Amgen also conducts clinical trials in patients.
"Amgen believes it has to have the full armamentarium of therapeutic choices to interact with biological systems," Bertram says.
...
Currently, Amgen's chemistry organization employs about 600 people, including medicinal, process, and analytical chemists, as well as chemical engineers, Bertram says. To be hired there, candidates must be outstanding in several respects, he observes. "In addition to core chemistry and science curriculum courses, we look for a blend of studies in strategic and project planning, general courses in biotechnology, management and leadership courses, and courses requiring team projects," he explains. -
3. Chemical & Engineering News: Employment Outlook - Drug Discovery And Development
pubs.acs.org/cen/employment/84 - [Cached]Published on: 11/7/2005 Last Visited: 11/29/2006
According to Steve Bertram, director of human resources for Amgen's research division, R&D there focuses on serious illness. Rather than limiting itself to only one type of therapeutic agent, such as small or large molecules, it develops agents that best fit the target. After testing a potential drug for efficacy in lab animals and healthy human volunteers, Amgen also conducts clinical trials in patients.
"Amgen believes it has to have the full armamentarium of therapeutic choices to interact with biological systems," Bertram says.
...
Currently, Amgen's chemistry organization employs about 600 people, including medicinal, process, and analytical chemists, as well as chemical engineers, Bertram says. To be hired there, candidates must be outstanding in several respects, he observes. "In addition to core chemistry and science curriculum courses, we look for a blend of studies in strategic and project planning, general courses in biotechnology, management and leadership courses, and courses requiring team projects," he explains.

